Evidence map›Paper›PMID 29285634›Full record

ArticlePsychopharmacology2018

Transient inactivation of the paraventricular nucleus of the thalamus enhances cue-induced reinstatement in goal-trackers, but not sign-trackers.

Brittany N Kuhn, Marin S Klumpner, Ignacio R Covelo, Paolo Campus, Shelly B Flagel

Abstract read
In one paragraph

Article in Psychopharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Effects of Pair Housing on Patency of Jugular Catheters in Rats (Journal of the American Association for Laboratory Animal Science : JAALAS · 2021
    Article
  15. Review
  16. Article
  17. The Contribution of Thalamic Nuclei in Salience Processing.Frontiers in behavioral neuroscience · 2021
    Review
  18. Article
  19. Article
  20. Mapping sign-tracking and goal-tracking onto human behaviors.Neuroscience and biobehavioral reviews · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Brittany N KuhnNeuroscience Graduate Program, University of Michigan, 4137 Undergraduate Science Building, 204 Washtenaw Avenue, Ann Arbor, MI, 48109, USA.
Marin S KlumpnerDepartment of Psychiatry, University of Michigan, 4250 Plymouth Road, Ann Arbor, MI, 48105, USA.
Ignacio R CoveloDepartment of Psychiatry, University of Michigan, 4250 Plymouth Road, Ann Arbor, MI, 48105, USA.
Paolo CampusDepartment of Psychiatry, University of Michigan, 4250 Plymouth Road, Ann Arbor, MI, 48105, USA.
Shelly B FlagelNeuroscience Graduate Program, University of Michigan, 4137 Undergraduate Science Building, 204 Washtenaw Avenue, Ann Arbor, MI, 48109, USA. sflagel@umich.edu.

Funding

POSTDOCTORAL TRAINING IN THE BIOLOGY OF DRUG ABUSET32DA007268 · NIDA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI TRAYNOR, JOHN R. · 1991 to 2021
$6.7M
Allosteric Modulation of the Mu-Opioid ReceptorR37DA039997 · NIDA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI TRAYNOR, JOHN R. · 2015 to 2024
$6.4M
NIDA Training Program in Neuroscience-Administrative SupplementT32DA007281 · NIDA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Shelly Beth Flagel · 1995 to 2026
$5.7M
Dynamic control of cue-driven behavior via the paraventricular thalamic nucleusR01DA038599 · NIDA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI FLAGEL, SHELLY BETH · 2015 to 2019
$2.7M
NIDA NIH HHS R01 DA038599NIDA NIH HHS T32 DA007268NIDA NIH HHS T32 DA007281
6 · The paper itself

Abstract

rationaleThe paraventricular nucleus of the thalamus (PVT) has been shown to mediate cue-motivated behaviors, such as sign- and goal-tracking, as well as reinstatement of drug-seeking behavior. However, the role of the PVT in mediating individual variation in cue-induced drug-seeking behavior remains unknown.

objectivesThis study aimed to determine if inactivation of the PVT differentially mediates cue-induced drug-seeking behavior in sign-trackers and goal-trackers.

methodsRats were characterized as sign-trackers (STs) or goal-trackers (GTs) based on their Pavlovian conditioned approach behavior. Rats were then exposed to 15 days of cocaine self-administration, followed by a 2-week forced abstinence period and then extinction training. Rats then underwent tests for cue-induced reinstatement and general locomotor activity, prior to which they received an infusion of either saline (control) or baclofen/muscimol (B/M) to inactivate the PVT.

resultsRelative to control animals of the same phenotype, GTs show a robust increase in cue-induced drug-seeking behavior following PVT inactivation, whereas the behavior of STs was not affected. PVT inactivation did not affect locomotor activity in either phenotype.

conclusionIn GTs, the PVT appears to inhibit the expression of drug-seeking, presumably by attenuating the incentive value of the drug cue. Thus, inactivation of the PVT releases this inhibition in GTs, resulting in an increase in cue-induced drug-seeking behavior. PVT inactivation did not affect cue-induced drug-seeking behavior in STs, suggesting that the role of the PVT in encoding the incentive motivational value of drug cues differs between STs and GTs.

Indexed as

CuesGoalsAnimalsCocaineConditioning, PsychologicalDopamine Uptake InhibitorsDose-Response Relationship, DrugDrug-Seeking BehaviorExtinction, PsychologicalMaleMidline Thalamic NucleiMotivationRatsRats, Sprague-DawleySelf AdministrationCocaineDopamine Uptake InhibitorsCocaineGoal-trackerIndividual variationParaventricular nucleus of the thalamusReinstatementRelapseReward cueSign-tracker

Identifiers

PMID29285634
PMCPMC5871598

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.